Hysteroscopic endometrial tumor localization and sentinel lymph node mapping. An upgrade of the hysteroscopic role in endometrial cancer patients
Vito Andrea Capozzi(University of Parma), Roberto Berretta(University of Parma), Giovanni Scambia(Agostino Gemelli University Polyclinic), Vito Chiàntera(University of Palermo), Virginia Vargiu(Agostino Gemelli University Polyclinic), Giulio Sozzi(University of Palermo), Alessandro Gioè(Agostino Gemelli University Polyclinic), Giuseppe Maglietta(University of Parma), Francesco Cosentino, Giulia Armano(University of Parma), Andrea Rosati(Agostino Gemelli University Polyclinic), Ursula Catena(Università Cattolica del Sacro Cuore), T. Ghi, Francesco Fanfani(Agostino Gemelli University Polyclinic), Attilio Di Spiezio Sardo(University of Naples Federico II), Elisa Scarpelli(University of Parma)
Cited by 3
Related Papers
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
|New England Journal of Medicine|2018|2.9k
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
|The Lancet Oncology|2017|1.9k
<scp>ISUOG</scp> Practice Guidelines: performance of first‐trimester fetal ultrasound scan
|Ultrasound in Obstetrics and Gynecology|2012|619
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial
|The Lancet Oncology|2021|412
Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta‐analysis
|Ultrasound in Obstetrics and Gynecology|2017|299